Novartis Investigative Site

Šiauliai, LTU LT-77156

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Relapsing Multiple Sclerosis

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling